Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

NCT02707523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Syncytial Virus

Interventions

DRUG: Azithromycin 10 mg
DRUG: Azithromycin 20mg
DRUG: Placebo

Sponsor

University of Alabama at Birmingham